Chemoradiation for locally advanced cervical cancer: Does it help?

Journal of Clinical Oncology

Volumn 20, Issue 4, 2002, Pages 891-893

  Rose, Peter G ^a   Bundy, Brian N ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN;

CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; DOSE RESPONSE; EDITORIAL; HUMAN; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; TREATMENT PLANNING; UTERINE CERVIX CARCINOMA;

EID: 0037083543     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.20.4.891     Document Type: Editorial

References (15)

1. A randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study
2. Pelvic radiation with concurrent chemotherapy versus pelvic and para-aortic radiation for high-risk cervical cancer: A randomized Radiation Therapy Oncology Group clinical trial
3. Cisplatin and 5-fluorouracil plus radiation therapy are superior to radiation therapy as adjunctive in high-risk early stage carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: Report of a phase III intergroup study
4. Concurrent cisplatin-based chemoradiation improves progression free and overall survival in advanced cervical cancer: Results of a randomized Gynecologic Oncology Group study
5. A comparison of weekly cisplatin during radiation therapy versus irradiation alone each followed by adjuvant hysterectomy in bulky stage IB cervical carcinoma: A randomized trial of the Gynecologic Oncology Group
6. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix
7. The effect of treatment duration in the local control of cervix cancer
8. The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: A patterns-of-care study
9. Uterine cervix
10. Clinical-pathologic study of stage IIB, III, and IVA carcinoma of the cervix: Extended diagnostic evaluation for paraaortic node metastasis - A Gynecologic Oncology Group study
11. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix
12. Hydroxyurea versus misonidazole with radiation in cervical carcinoma: Long-term follow-up of a Gynecologic Oncology Group Trial
13. Irradiation with or without misonidazole for patients with stage IIIB and IVA carcinoma of the cervix: Final results of RTOG 80-05 Radiation Therapy Oncology Group
14. Prophylactic extended-field irradiation of para-aortic lymph node in stages IIB and bulky IB and IIA cervical carcinomas: Ten-year treatment results of RTOG 79-20